Skip to main content
STVN
NYSE Life Sciences

Stevanato Group Affirms 2026 Adjusted EPS Guidance at EUR0.59-EUR0.63

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
7
Price
$19.599
Mkt Cap
$5.187B
52W Low
$12.89
52W High
$28
Market data snapshot near publication time

summarizeSummary

Stevanato Group has provided or reaffirmed its adjusted earnings per share (EPS) guidance for fiscal year 2026, setting the range at EUR0.59 to EUR0.63. This guidance is a key input for investor models and helps set market expectations for the company's future profitability. Traders will integrate this outlook into their valuation assessments, influencing positioning decisions. Investors will now monitor future earnings reports and any updates to this guidance for confirmation or revision of the company's financial trajectory.

At the time of this announcement, STVN was trading at $19.60 on NYSE in the Life Sciences sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $12.89 to $28.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed STVN - Latest Insights

STVN
May 07, 2026, 6:37 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
STVN
Mar 04, 2026, 4:10 PM EST
Filing Type: 6-K
Importance Score:
8
STVN
Mar 04, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
8